The differential interferon responses of two strains of Stat1-deficient mice do not alter susceptibility to HSV-1 and VSV in vivo

Virology

Volumn 450-451, Issue , 2014, Pages 350-354

  Katzenell, Sarah ^a   Chen, Yufei ^a   Parker, Zachary M ^a   Leib, David A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Herpes simplex virus; Innate immunity; Stat1; Vesicular stomatitis virus

Indexed keywords

IFIT1 PROTEIN; INTERFERON; STAT1 PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN; VIRUS RNA;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CONTROLLED STUDY; DNA BINDING DOMAIN STRAIN; DNA BINDING MOTIF; EMBRYO; FIBROBLAST; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MOUSE; MOUSE STRAIN; N TERMINAL DOMAIN STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; STRAIN DIFFERENCE; UPREGULATION; VESICULAR STOMATITIS VIRUS; VIRUS IDENTIFICATION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

HERPES SIMPLEX VIRUS; INNATE IMMUNITY; STAT1; VESICULAR STOMATITIS VIRUS;

ANIMALS; DISEASE SUSCEPTIBILITY; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; INTERFERONS; MICE; MICE, KNOCKOUT; PROTEIN STRUCTURE, TERTIARY; STAT1 TRANSCRIPTION FACTOR; VESICULAR STOMATITIS; VESICULAR STOMATITIS INDIANA VIRUS; VIRUS REPLICATION;

EID: 84892464283     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.12.015     Document Type: Article

References (30)

1. Bente D.A., Alimonti J.B., Shieh W.J., Camus G., Stroher U., Zaki S., Jones S.M. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J. Virol. 2010, 84:11089-11100.
2. Bluyssen H.A., Vlietstra R.J., Faber P.W., Smit E.M., Hagemeijer A., Trapman J. Structure, chromosome localization, and regulation of expression of the interferon-regulated mouse Ifi54/Ifi56 gene family. Genomics 1994, 24:137-148.
3. Boisson-Dupuis S., Kong X.F., Okada S., Cypowyj S., Puel A., Abel L., Casanova J.L. Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr. Opin. Immunol. 2012, 24:364-378.
4. Bowick G.C., Airo A.M., Bente D.A. Expression of interferon-induced antiviral genes is delayed in a STAT1 knockout mouse model of Crimean-Congo hemorrhagic fever. Virol. J. 2012, 9:122.
5. Chan S.R., Vermi W., Luo J., Lucini L., Rickert C., Fowler A.M., Lonardi S., Arthur C., Young L.J., Levy D.E., Welch M.J., Cardiff R.D., Schreiber R.D. STAT1-deficient mice spontaneously develop estrogen receptor alpha-positive luminal mammary carcinomas. Breast Cancer Res. BCR 2012, 14:R16.
6. Durbin J.E., Hackenmiller R., Simon M.C., Levy D.E. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 1996, 84:443-450.
7. Fensterl V., Wetzel J.L., Ramachandran S., Ogino T., Stohlman S.A., Bergmann C.C., Diamond M.S., Virgin H.W., Sen G.C. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog. 2012, 8:e1002712.
8. Halford W.P., Weisend C., Grace J., Soboleski M., Carr D.J., Balliet J.W., Imai Y., Margolis T.P., Gebhardt B.M. ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency. Virol. J. 2006, 3:44.
9. Hix L.M., Karavitis J., Khan M.W., Shi Y.H., Khazaie K., Zhang M. Tumor STAT1 transcription factor activity enhances breast tumor growth and immune suppression mediated by myeloid-derived suppressor cells. J. Biol. Chem. 2013, 288:11676-11688.
10. Hofer M.J., Li W., Manders P., Terry R., Lim S.L., King N.J., Campbell I.L. Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus. J. Virol. 2012, 86:6932-6946.
11. Khodarev N.N., Beckett M., Labay E., Darga T., Roizman B., Weichselbaum R.R. STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc. Nat. Acad. Sci. U.S.A. 2004, 101:1714-1719.
12. Klover P.J., Muller W.J., Robinson G.W., Pfeiffer R.M., Yamaji D., Hennighausen L. Loss of STAT1 from mouse mammary epithelium results in an increased Neu-induced tumor burden. Neoplasia 2010, 12:899-905.
13. Kumar A., Commane M., Flickinger T.W., Horvath C.M., Stark G.R. Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 1997, 278:1630-1632.
14. Leib D.A., Machalek M.A., Williams B.R., Silverman R.H., Virgin H.W. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc. Nat. Acad. Sci. U.S.A. 2000, 97:6097-6101.
15. Lew D.J., Decker T., Darnell J.E. Alpha interferon and gamma interferon stimulate transcription of a single gene through different signal transduction pathways. Mol. Cell. Biol. 1989, 9:5404-5411.
16. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
17. Meraz M.A., White J.M., Sheehan K.C., Bach E.A., Rodig S.J., Dighe A.S., Kaplan D.H., Riley J.K., Greenlund A.C., Campbell D., Carver-Moore K., DuBois R.N., Clark R., Aguet M., Schreiber R.D. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996, 84:431-442.
18. Mossman K.L., Ashkar A.A. Herpesviruses and the innate immune response. Viral Immunol. 2005, 18:267-281.
19. O'Shea J.J., Gadina M., Kanno Y. Cytokine signaling: birth of a pathway. J. Immunol. 2011, 187:5475-5478.
20. Pasieka T.J., Cilloniz C., Lu B., Teal T.H., Proll S.C., Katze M.G., Leib D.A. Host responses to wild-type and attenuated herpes simplex virus infection in the absence of Stat1. J. Virol. 2009, 83:2075-2087.
21. Pasieka T.J., Collins L., O'Connor M.A., Chen Y., Parker Z.M., Berwin B.L., Piwnica-Worms D.R., Leib D.A. Bioluminescent imaging reveals divergent viral pathogenesis in two strains of Stat1-deficient mice, and in alphassgamma interferon receptor-deficient mice. PLoS One 2011, 6:e24018.
22. Pasieka T.J., Lu B., Leib D.A. Enhanced pathogenesis of an attenuated herpes simplex virus for mice lacking Stat1. J. Virol. 2008, 82:6052-6055.
23. Rader K.A., Ackland-Berglund C.E., Miller J.K., Pepose J.S., Leib D.A. In vivo characterization of site-directed mutations in the promoter of the herpes simplex virus type 1 latency-associated transcripts. J. Gen. Virol. 1993, 74(Pt 9):1859-1869.
24. Schindler C., Levy D.E., Decker T. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 2007, 282:20059-20063.
25. Schindler U., Wu P., Rothe M., Brasseur M., McKnight S.L. Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity 1995, 2:689-697.
26. Shresta S., Sharar K.L., Prigozhin D.M., Snider H.M., Beatty P.R., Harris E. Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J. Immunol. 2005, 175:3946-3954.
27. Stark G.R., Darnell J.E. The JAK-STAT pathway at twenty. Immunity 2012, 36:503-514.
28. Strelow L.I., Leib D.A. Role of the virion host shutoff (vhs) of herpes simplex virus type 1 in latency and pathogenesis. J. Virol. 1995, 69:6779-6786.
29. Vinkemeier U., Cohen S.L., Moarefi I., Chait B.T., Kuriyan J., Darnell J.E. DNA binding of in vitro activated Stat1 alpha, Stat1 beta and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites. EMBO J. 1996, 15:5616-5626.
30. Waibler Z., Detje C.N., Bell J.C., Kalinke U. Matrix protein mediated shutdown of host cell metabolism limits vesicular stomatitis virus-induced interferon-alpha responses to plasmacytoid dendritic cells. Immunobiology 2007, 212:887-894.